[go: up one dir, main page]

DE69824881D1 - Kompakte replikons des epstein-barr-virus. - Google Patents

Kompakte replikons des epstein-barr-virus.

Info

Publication number
DE69824881D1
DE69824881D1 DE69824881T DE69824881T DE69824881D1 DE 69824881 D1 DE69824881 D1 DE 69824881D1 DE 69824881 T DE69824881 T DE 69824881T DE 69824881 T DE69824881 T DE 69824881T DE 69824881 D1 DE69824881 D1 DE 69824881D1
Authority
DE
Germany
Prior art keywords
replicons
compact
barr virus
epstein barr
epstein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69824881T
Other languages
English (en)
Other versions
DE69824881T2 (de
Inventor
Brian Seed
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Publication of DE69824881D1 publication Critical patent/DE69824881D1/de
Application granted granted Critical
Publication of DE69824881T2 publication Critical patent/DE69824881T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/25—Varicella-zoster virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16241—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16243—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE1998624881 1997-06-19 1998-04-14 Kompakte replikons des epstein-barr-virus. Expired - Fee Related DE69824881T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5020697P 1997-06-19 1997-06-19
US50206P 1997-06-19
PCT/US1998/007641 WO1998057658A1 (en) 1997-06-19 1998-04-14 Compact epstein-barr virus replicons

Publications (2)

Publication Number Publication Date
DE69824881D1 true DE69824881D1 (de) 2004-08-05
DE69824881T2 DE69824881T2 (de) 2004-11-18

Family

ID=21963948

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1998624881 Expired - Fee Related DE69824881T2 (de) 1997-06-19 1998-04-14 Kompakte replikons des epstein-barr-virus.

Country Status (20)

Country Link
US (1) US6133025A (de)
EP (1) EP1032418B1 (de)
JP (1) JP2002505586A (de)
KR (1) KR100569826B1 (de)
CN (1) CN1263861C (de)
AR (1) AR054291A1 (de)
AT (1) ATE270341T1 (de)
AU (1) AU744680B2 (de)
BR (1) BR9810055A (de)
CA (1) CA2293299A1 (de)
DE (1) DE69824881T2 (de)
DK (1) DK1032418T3 (de)
ES (1) ES2224382T3 (de)
HU (1) HUP0003971A3 (de)
ID (1) ID24649A (de)
PL (1) PL337528A1 (de)
PT (1) PT1032418E (de)
RU (1) RU2240348C2 (de)
TR (1) TR199903155T2 (de)
WO (1) WO1998057658A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10421950B2 (en) * 2001-05-07 2019-09-24 National Research Council Of Canada Enhanced production of recombinant proteins by transient transfection of suspension-growing mammalian cells
US8637315B2 (en) * 2008-05-15 2014-01-28 National Research Council Of Canada Process, vectors and engineered cell lines for enhanced large-scale transfection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939088A (en) * 1987-02-18 1990-07-03 Meloy Laboratories Inc. Sustained production of recombinant gamma interferon using an Epstein-Barr virus replicon

Also Published As

Publication number Publication date
EP1032418A4 (de) 2002-01-02
CN1263861C (zh) 2006-07-12
ID24649A (id) 2000-07-27
PL337528A1 (en) 2000-08-28
HUP0003971A3 (en) 2003-03-28
BR9810055A (pt) 2000-09-12
AR054291A1 (es) 2007-06-20
WO1998057658A1 (en) 1998-12-23
KR20010013901A (ko) 2001-02-26
RU2240348C2 (ru) 2004-11-20
US6133025A (en) 2000-10-17
JP2002505586A (ja) 2002-02-19
ES2224382T3 (es) 2005-03-01
AU744680B2 (en) 2002-02-28
CA2293299A1 (en) 1998-12-23
DK1032418T3 (da) 2004-11-01
EP1032418B1 (de) 2004-06-30
ATE270341T1 (de) 2004-07-15
CN1278185A (zh) 2000-12-27
DE69824881T2 (de) 2004-11-18
EP1032418A1 (de) 2000-09-06
KR100569826B1 (ko) 2006-04-11
TR199903155T2 (en) 2000-09-21
PT1032418E (pt) 2004-10-29
AU7123998A (en) 1999-01-04
HUP0003971A2 (en) 2001-03-28

Similar Documents

Publication Publication Date Title
NL1007590A1 (nl) Hydroxyfenyltriazinen.
NL1007031A1 (nl) Hydroxyfenyltriazinen.
NO20003302D0 (no) Vaksine
KR970704468A (ko) 폴리에피토프 백신(polyepitope vaccines)
DK0810877T3 (da) Hepatitis B-vaccine
DE59800452D1 (de) Lagerstabile, permanent wasserbenetzbare, vulkanisate ergebende polysiloxanmasse
TR199501653A2 (tr) Silikonlu bilesimler.
NO950743L (no) Rörfri, innfattet, teleskopert ammunisjon
TR199501351A2 (tr) Uzatilmis sürede cisaprid saliverilmesi.
FI971817A7 (fi) Tartuntaelin
FI914437A7 (fi) Anordning foer stapling av ark.
FI904997A7 (fi) Foerfarande foer bestaemning av ingrediensinhalter av gas.
TR199501652A2 (tr) Silikonlu bilesimler.
ES1038014Y (es) Cajon.
DE69824881D1 (de) Kompakte replikons des epstein-barr-virus.
TR199501647A2 (tr) Silikonlu bilesimler.
DE69718855D1 (de) Schleuder
DE69110746D1 (de) Gasbeheiztes Gerät.
FI97267C (fi) Ampumatuki
ES1027890Y (es) Pieza ceramica perfeccionada.
FI944558A0 (fi) Virus
ES1037887Y (es) Cajon perfeccionado.
DK1122245T3 (da) 2-Aminobenzoxazinoner til behandling af virale infektioner
BR9602550A (pt) Touca reeletora térmica
BR9705955A (pt) Tabuada cibernética

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee